4.19

4.49% 0.18

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $4.19, with a volume of 1.45M. It is up +4.49% in the last 24 hours and up +52.36% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$4.01

Open:

$4.13

24h Volume:

1.45M

Relative Volume:

1.97

Market Cap:

$271.82M

Revenue:

$207.32M

Net Income/Loss:

$-61.04M

P/E Ratio:

-4.3751

EPS:

-0.9577

Net Cash Flow:

$-25.97M

1W Performance:

+7.16%

1M Performance:

+52.36%

6M Performance:

+68.27%

1Y Performance:

-23.26%

1-Day Range:

$4.05

$4.375

1-Week Range:

$3.755

$4.469

52-Week Range:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1104)

Industry

Medical Devices (141)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	4.19	271.82M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	88.41	153.99B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	307.80	118.00B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	79.34	101.86B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	45.29	67.32B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	87.36	50.30B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Jun 19, 2026

Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary - Quartr

Jun 18, 2026

Treace treats its first patient with HyperPlate XM foot implant - Stock Titan

Jun 18, 2026

Treace Medical Concepts Inc - TradingKey

Jun 18, 2026